BioProtein Technologies is a French transgenic animal company specializing in Contract Manufacturing of recombinant proteins and vaccines in the milk of transgenic rabbits. The Company has a strong expertise through the entire manufacturing process from molecular biology and transgene design, through animal production, breeding and milking.

BioProtein Technologies is a Contract Manufacturing Organization, whose mission is to provide the pharmaceutical and biotechnology industries with recombinant proteins and vaccines manufactured in the milk of transgenic rabbits. The company´s transgenic production model offers customized packages of appropriate quantities of purified proteins and vaccines, from mg to kg quantities within a competitive timeframe and low capital and operationnal costs compared to traditional mammalian expression systems.

Transgenic rabbit is an alternative production system for the production of recombinant proteins and vaccines and is the most suitable animal to produce hundred grams to kilograms of recombinant proteins. Rabbit has been chosen for its short duration of gestation and maturity, thus allowing a fast production of transgenic lines as well as for its proximity to humans in terms of glycosylation processing.

Additional information is provided online.